Back

High-normal thyroid-stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation for atrial fibrillation

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Atrial fibrillation - Ablation Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Itsuro Morishima

Ogaki Municipal Hospital, Ogaki (Japan)

19 More presentations in this session

Presentation thumbnail
Personalized ablation strategy in patients with long-standing persistent atrial fibrillation and chronic heart failure.
Doctor V. Orshanskaya (Saint Petersburg, RU)
Presentation thumbnail
Clinical impact of thyroxin levels on recurrence of atrial fibrillation after catheter ablation for patients without thyroid dysfunction: a multicenter study
Doctor T. Yonishi (Osaka, JP)
Abstract Slides
Presentation thumbnail
Improvement in quality of life in patients that underwent catheter ablation for persistent atrial fibrillation.
Doctor K. Nakajima (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Association of coronary artery disease and revascularization with recurrence of atrial fibrillation after catheter ablation
Doctor D. Hiraya (Tsukuba, JP)
Abstract
Presentation thumbnail
Patient-reported outcomes in relation to continuously monitored rhythm before and during two years after atrial fibrillation ablation using a disease-specific and a generic instrument
Doctor A. Bjorkenheim (Orebro, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Atrial fibrillation - Ablation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources